Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=enzLatest Financial News for ENZO BIOCHEM INCen-usWed, 16 Dec 2009 18:04:24 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=enzyahoo_finance/2836856669Wed, 16 Dec 2009 18:04:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091214/suisse15.html?.v=1yahoo_finance/176964799Mon, 14 Dec 2009 16:16:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/e/enz.htmlyahoo_finance/2122007433Sat, 12 Dec 2009 14:21:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1349bbqku/*http%3A//www.fool.com/investing/general/2009/12/11/enzo-biochem-inc-warming-up-or-cooling-off.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3447744426Fri, 11 Dec 2009 17:45:49 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/enz8-k.htmlyahoo_finance/4138771657Fri, 11 Dec 2009 11:00:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091210/us_earns_enzo_biochem.html?.v=1Biotechnology company Enzo Biochem Inc. said Thursday its 2010 fiscal first-quarter loss narrowed on a boost in laboratory services and product revenue.yahoo_finance/1817544479Thu, 10 Dec 2009 21:57:22 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091210/us_enzo_biochem_contract.html?.v=2Enzo Biochem Inc. said Thursday it signed a marketing deal covering New York and New Jersey with Ikonisys Inc. for a molecular cervical cancer test.yahoo_finance/512798147Thu, 10 Dec 2009 21:41:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091210/enz10-q.htmlyahoo_finance/3496255301Thu, 10 Dec 2009 21:25:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091210/20091210006095.html?.v=1NEW YORK----Enzo Biochem, Inc. , a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, today reported for the fiscal first quarter ended October 31, 2009, record operating revenues and sharply improved operating results.yahoo_finance/547780571Thu, 10 Dec 2009 21:10:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091210/shove11.html?.v=1yahoo_finance/3148405378Thu, 10 Dec 2009 16:55:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091210/20091210005750.html?.v=1NEW YORK----Enzo Biochem, Inc. announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys’ proprietary oncoFISH® cervical test, a laboratory developed test for cervical cancer prevention.yahoo_finance/1672436308Thu, 10 Dec 2009 16:43:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091207/20091207006141.html?.v=1NEW YORK----Enzo Biochem, Inc. , will hold a conference call to discuss its fiscal 2010 first quarter results on Friday, December 11, 2009, at 8:30 AM ET.yahoo_finance/1568788109Mon, 7 Dec 2009 18:56:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ijf03no/*http%3A//online.wsj.com/article/SB10001424052748703735004574570301744790302.html?ru=yahoo&mod=yahoo_hsyahoo_finance/803137428Wed, 2 Dec 2009 02:26:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091127/enz8-k.htmlyahoo_finance/3926567905Fri, 27 Nov 2009 11:00:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091125/20091125005765.html?.v=1NEW YORK----Enzo Biochem, Inc. announced today that its Board of Directors approved the termination of Shahram K. Rabbani’s services as the Company’s Secretary and Treasurer, respectively, effective immediately.yahoo_finance/3853394830Wed, 25 Nov 2009 23:19:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091118/20091118005593.html?.v=1NEW YORK----Enzo Biochem, Inc. today announced that it has entered into an agreement with GeneNews , of Toronto, Canada, for exclusive rights to market GeneNews’ ColonSentry™, a proprietary blood test for colorectal cancer, in the states of New York and New Jersey.yahoo_finance/3745959991Wed, 18 Nov 2009 12:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091113/20091113005453.html?.v=1NEW YORK----Enzo Biochem Inc. announced today that David Goldberg, Vice President, Corporate Development, will speak on the Company’s extensive oral immune regulation platform at the Windhover TA Partnerships 2009 conference in Boston, MA, on Wednesday, November 18, 2009, where Enzo’s EGS21, an orally administered beta glucosylceramide formulation, now undergoing clinical study, was named one of this year’s “top 10 inflammatory/autoimmune projects to watch.”yahoo_finance/3274850492Fri, 13 Nov 2009 15:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091111/20091111006063.html?.v=1NEW YORK----Enzo Biochem, Inc. , a leading vertically integrated clinical lab, life sciences and therapeutic biotechnology company, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 3:40 PM at The St.yahoo_finance/987874656Wed, 11 Nov 2009 20:23:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104005755.html?.v=1VIENNA----Enzo Biochem, Inc. today reported on the Company’s therapeutic platforms utilizing oral immune regulation for immune mediated diseases at the Bio-Europe 2009 15th Annual International Conference here calling it a “bright area of therapeutic promise.”yahoo_finance/3568531389Wed, 4 Nov 2009 13:53:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091102/20091102005636.html?.v=1BOSTON----Enzo Biochem Inc. announced today that favorable results of the Company’s clinical trial for treatment of non-alcoholic steatohepatitis were presented at the annual meeting of the American Association for the Study of Liver Diseases.yahoo_finance/1719043257Mon, 2 Nov 2009 14:00:00 Etc/GMT